Midazolam In Sodium Chloride Injection, Solution
Product Images NDC 25021-688

This is a description for a medication called Midazolam in a single-dose container for intravenous administration. The container contains 50 mg of Midazolam per 50 mL in 0.9% Sodium Chloride Injection, with a concentration of 1 mg per mL. It is sterile, nonpyrogenic, preservative-free, and PVC and DEHP-free. The container closure does not contain natural rubber latex. It is advised not to add supplementary medication or use in series connections. The recommended dosage is available in the package insert. The container should be checked for leaks by squeezing, and if leaks are found, it should be discarded due to potential impaired sterility. The storage temperature ranges from 20° to 25°C (68° to 77°F) with excursions permitted between 15° and 30°C (59° and 86°F). Individual containers can be used up to 48 hours after initial penetration, but freezing should be avoided, and any unused portion should be discarded. The medication is manufactured by SAGENT Pharmaceuticals in Schaumburg, IL, USA, and it is made in India.*

This is a description of a 100 mL single-dose container containing Midazolam in 0.9% Sodium Chloride Injection. It is a high alert medication, with each mL containing 1 mg of Midazolam. The container is sterile, non-preservative-free, PVC-free, and DEHP-free. It is advised not to add supplementary medication or use in series connections. The recommended dosage can be found in the package insert. It should be stored between 20° to 25°C (68° to 77°F) with excursions allowed between 15° and 30°C (59° and 86°F). The container can be used up to 48 hours after initial penetration. It is important not to freeze the product and to discard any unused portion.*